ISPOR EU Exhibit Hall Theater - Live
From Routine Care to Decision-Grade Evidence: Scaling Pragmatic Trials Across Health Systems
November 10, 15:15-15:45 CET
Theater 2
Presentation objectives:
-
Describe the role pragmatic trials in generating comparative effectiveness evidence for HTA, FDA, and regulatory decision-making
-
Identify strategies for embedding randomization into routine clinical care, including cluster randomization and standardized care pathways
-
Assess opportunities and challenges in using pragmatic trials to address real-world evidence gaps
Speakers
![]() |
Bruce Feinberg, DO Chief Medical Officer |
![]() |
Nicholas Lazarou, MPH, MBA Sr. Director, Science, Data and Delivery |




